Aerpio Pharmaceuticals Total Assets

Aerpio Pharmaceuticals (ARPO) currently reports a total assets of $130M as of March 2026. That compares with $230M in the prior-year period — down 45.6% year over year. Use the charts on this page to explore Aerpio Pharmaceuticals's total assets history and peer comparisons.

Aerpio Pharmaceuticals's total assets decreased from $230M to $130M — a 45.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aerpio Pharmaceuticals reported $130M in total assets as of March 2026. That compares with $230M in the prior-year period — down 45.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aerpio Pharmaceuticals, and consider following ARPO for alerts when major investors trade the stock.

Aerpio Pharmaceuticals is classified in the Healthcare sector. On total assets, it currently shows $130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARPO with unrelated industries.